Treg-mediated suppression of tumor-specific CTL responses have also been identified within the tumor DLN, such as the identification of TGFβ-secreting Tregs in tumor DLN promoting tumor malignancy in breast cancer (47). This evidence concerns the gene TGFB1 and breast cancer.